ADIPOQ and type 2 diabetes mellitus: In contrast, select SCFAs had no effect on adiponectin gene expression in obese primary adipose tissue; however, adiponectin gene expression increased with SCFA treatment or adipose tissue from obese donors with concurrent type 2 diabetes, thereby indicating that the adipose tissue microenvironment and metabolic status may impact how the tissue responds to SCFA signaling [72].